|
| Type of Disease | Total | ||||
| Patients with PE* N = 55 | Patients with PH** N = 20 | Patients with CTEPH*** N = 25 | Normal Subjects N = 50 | |||
| Age | 21 - 30 | 3 (5.5%) | 1 (5.0%) | 0 (0.0%) | 5 (10.0%) | 9 (6.0%) |
| 31 - 40 | 7 (12.7%) | 3 (15.0%) | 0 (0.0%) | 12 (24.0%) | 22 (14.7%) | |
| 41 - 50 | 11 (20.0%) | 0 (0.0%) | 4 (16.0%) | 10 (20.0%) | 25 (16.7%) | |
| 51 - 60 | 18 (32.7%) | 4 (20.0%) | 11 (44.0%) | 8 (16.0%) | 41 (27.3%) | |
| 61 - 70 | 11 (20.0%) | 7 (35.0%) | 6 (24.0%) | 12 (24.0%) | 36 (24.0%) | |
| ˃71 | 5 (9.1%) | 5 (25.0%) | 4 (16.0%) | 3 (6.0%) | 17 (11.3%) | |